| abstract |
The present invention provides a method for binding and using an androgen receptor targeted drug (ARTA). Drugs define a novel subclass of selective androgen receptor modulator (SARM) compounds. Several SARM compounds have been found to have the unpredictable androgenic and anabolic activities of non-steroidal ligands for androgen receptors. These SARM compounds are used to inhibit spermatogenesis, male contraception, hormonal treatment, hormone replacement therapy, treatment of hormone-related conditions, prostate cancer, and dry icon condition. [Selection figure] None |